Skip to content

Weekday Japan business intelligence for finance professionals.

Join the list
Tokyo Brief東 京 ブ リ ー フJapan's day, wrapped and delivered by morning.
Company4 articles
Companies

M3, Inc.

Latest Tokyo Brief coverage on M3, Inc., tracking filings, financial news, and market signals from Japan.

Code
2413
Exchange
TSE
Coverage
4 articles

Latest coverage

TSE:2413

  1. Oasis Management Lifts M3 Stake to 8.46%, Reserves Right to Push for Board Shake-Up

    Oasis Management's stake in M3 climbed to 8.46% from 7.40% through months of market buying funded by fund capital rather than borrowed money, and the fund now has notice on file that it may push for the dismissal of M3's representative director, changes to the board, delisting, or a takeover crossing majority control within the next year.

  2. Oasis Management Raises M3 Stake to 7.40% and Proposes Delisting

    Activist fund Oasis Management now holds 7.40% of M3, Inc., up from 6.26%, after a roughly ¥82.3bn buying spree funded entirely from fund capital, and it says it has already proposed delisting the shares and, separately, a third-party share acquisition that would leave that party holding a majority of voting rights, with dismissal of the representative director and a dividend-policy fight flagged as possible next steps.

  3. Oasis Raises M3 Stake to 6.26% and Puts Board Removal, Delisting on the Table

    Oasis Management's amended EDINET filing shows its M3, Inc. stake climbing to 6.26% from 5.03%, funded by ¥68.7bn in fund capital, with a stated plan to seek the representative director's removal, board changes, a dividend-policy rewrite, or delisting within the next year, and to potentially buy more shares.

  4. M3 turns to Wiseman to deepen its care-software reach

    M3 plans to acquire 242 Wiseman shares, or 100% of the company, with execution slated for July 1 and funding from cash on hand. The strategic logic is installed base: Wiseman sells care and welfare systems to operators, medical facilities and local governments, while M3 says the target adds dense coverage in elder-care workflows it can pair with AI features, cross-selling and links between care software and cloud medical records. The price is undisclosed, so the rationale is clear but the valuation remains politely offstage.